PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Multiple research teams unable to confirm high-profile Alzheimer's study

2013-05-24
(Press-News.org) Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

Those results, presented online Feb. 9, 2012, suggested that the drug bexarotene (marketed as Targretin®) could rapidly reverse the buildup of beta amyloid plaques (Aβ) — a pathological hallmark of Alzheimer's disease — in the brains of mice. According to the authors of the 2012 report, drug treatment quickly removed most of the plaques and brought rapid reversal of the pathological, cognitive and memory deficits related to the onset of Alzheimer's.

However, the new reports from extensive and carefully controlled studies did not show any reduction in the number of plaques or total area occupied by the plaques during or after treatment. These results are described in three "technical comments" — one of which comes from researchers at the University of Chicago, Northwestern University, Massachusetts General Hospital, Washington University in St Louis and University of Tubingen in Germany — to be published in the May 24, 2013, issue of Science.

"The drug has no impact on plaque burden in three strains that exhibit Aβ amyloidosis," according to that group's comment. "We have failed to support earlier findings by Cramer et al that Targretin is efficacious in reducing plaque burden in transgenic mouse models of cerebral Aβ deposition."

Comment co-author Sangram Sisodia, PhD, professor of neurosciences at the University of Chicago, said he and his colleagues were curious about the initial report in 2012.

"We were surprised and excited, even stunned, when we first saw these results presented at a small conference," said Sisodia. "The mechanism of action made some sense, but the assertion that they could reduce the areas of plaque by 50 percent within three days, and by 75 percent in two weeks, seemed too good to be true."

"We all went back to our labs and tried to confirm these promising findings," Sisodia added. "We repeated the initial experiments — a standard process in science. Combined results are really important in this field. None of us found anything like what they described in the 2012 paper."

The researchers found no effects on plaque burden in three different strains of mice that were treated with bexarotene.

The discrepancy, besides being disappointing, also raises concerns about patient safety. The Food and Drug Administration approved bexarotene in December 1999 for a very specific use: treatment of refractory cutaneous T-cell lymphoma, a type of skin cancer. Once approved, the drug became legally available by prescription for "off-label" uses as well.

"Anecdotally, we have all heard that physicians are treating their Alzheimer's patients with bexarotene, a cancer drug with severe side effects," said co-author Robert Vassar, PhD, professor of cell and molecular biology at Northwestern University Feinberg School of Medicine. "This practice should be ended immediately, given the failure of three independent research groups to replicate the plaque-lowering effects of bexarotene."

Bexarotene has never been tested as a treatment for Alzheimer's disease in humans, not even to determine the optimal dose or duration of treatment. This drug has significant side effects, including major blood-lipid abnormalities, pancreatitis, liver function test abnormalities, thyroid axis alterations, leucopenia, headaches, fatigue, weight gain, depression, nausea, vomiting, constipation and rash.

The two other technical comments came from research teams led by Kevin Felsenstein, Todd Golde, David Borchelt and colleagues at the University of Florida and by Bart DeStrooper and colleagues at the University of Leuven, Belgium.

There is no cure or effective treatment for Alzheimer's disease, which is a progressive type of dementia that occurs when nerve cells in the brain die. When Alzheimer's was first identified in 1906, it was considered a rare disorder. Today, Alzheimer's is the most common cause of dementia. An estimated 5.3 million Americans have the disease.

### This work was supported by the Cure Alzheimer's Fund. Additional authors include Karthikeyan Veeraraghavalu of the University of Chicago; Rudolph Tanzi, Can Zhang and Sean Miller of Massachusetts General Hospital; Jasmin K. Hefendehl and Mathias Jucker of the University of Tübingen; Tharinda W. Rajapaksha and Robert Vassar of Northwestern University Feinberg School of Medicine; and Jason Ulrich and David M. Holtzman from the Washington University School of Medicine.


ELSE PRESS RELEASES FROM THIS DATE:

Antibiotics: A new understanding of sulfonamide nervous system side effects

2013-05-24
Since the discovery of Prontosil in 1932, sulfonamide antibiotics have been used to combat a wide spectrum of bacterial infections, from acne to chlamydia and pneumonia. However, their side effects can include serious neurological problems like nausea, headache, dizziness, hallucinations and even psychosis. In a recent Science publication, EPFL researchers have shown for the first time how sulfonamides can interfere with a patient's nervous system. The problem is that, even though we know how sulfonamides work, we do not understand the actual molecular mechanics behind ...

NIH scientists discover molecule triggers sensation of itch

2013-05-24
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as the sensation of itch. The small molecule, called natriuretic polypeptide b (Nppb), streams ahead and selectively plugs into a specific nerve cell in the spinal cord, which sends the signal onward through the central nervous system. When Nppb or its nerve cell was removed, mice stopped scratching at a broad array of itch-inducing substances. The signal wasn't going ...

Bittersweet: Bait-averse cockroaches shudder at sugar

2013-05-24
VIDEO: This movie shows the preferences of wild type and glucose-averse cockroaches for off-the-shelf store-bought foods with and without glucose. Click here for more information. Sugar isn't always sweet to German cockroaches, especially to the ones that avoid roach baits. In a study published May 24 in the journal Science, North Carolina State University entomologists show the neural mechanism behind the aversion to glucose, the simple sugar that is a popular ingredient ...

Astronomers team up with the public to solve decade old puzzle

2013-05-24
An extremely precise measurement of the distance to a star system has finally allowed astronomers to solve a decade-old puzzle, confirming understanding of the way exotic objects like black holes interact with nearby stars. Published today in prestigious journal Science, a team of astronomers headed by Dr James Miller-Jones from the Curtin University node of the International Centre for Radio Astronomy Research (ICRAR), have measured the distance to star system SS Cygni to be 372 light years, much closer than a previous measurement made by the Hubble Space Telescope in ...

Economic incentives increase blood donation without negative consequences

2013-05-24
Can economic incentives such as gift cards, T-shirts, and time off from work motivate members of the public to increase their donations of blood? A team of researchers including Johns Hopkins Carey Business School Assistant Professor Mario Macis says the answer is an emphatic yes. Pointing to a large body of recent research that supports their argument, the three economists write in the May 24, 2013, issue of Science that the World Health Organization and national blood collection agencies should reconsider their opposition to economic incentives for much-needed blood ...

Accurate distance measurement resolves major astronomical mystery

2013-05-24
Sometimes astronomy is like real estate -- what's important is location, location, and location. Astronomers have resolved a major problem in their understanding of a class of stars that undergo regular outbursts by accurately measuring the distance to a famous example of the type. The researchers used the National Science Foundation's Very Long Baseline Array (VLBA) and the European VLBI Network (EVN) to precisely locate one of the most-observed variable-star systems in the sky -- a double-star system called SS Cygni -- at 370 light-years from Earth. This new distance ...

Drug reverses Alzheimer's disease deficits in mice, Pitt research confirms

2013-05-24
An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science. The research, funded by the National Institutes of Health's National Institute on Aging and Alzheimer's Association, reviewed previously published findings on the drug bexarotene, approved by the U.S. Food and Drug Administration for use in cutaneous T cell lymphoma. The Pitt Public Health researchers were able to verify that the drug does significantly improve cognitive deficits in mice ...

UEA scientists make breast cancer advance that turns previous thinking on its head

2013-05-24
UEA scientists make breast cancer advance that turns previous thinking on its head Scientists at the University of East Anglia have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function. New research published today in the Journal of Biological Chemistry reveals that an enzyme called MMP-8 (matrix metalloproteinase-8) could be acting as a locator to the immune system, which then becomes activated to attack tumours. It was originally thought that the production of MMPs by breast cancer cells ...

Giving blood donors a good reason to give

2013-05-24
Canada and other countries should reassess guidelines that prohibit offering economic incentives such as gift cards to potential blood donors, says a study from the University of Toronto Mississauga (UTM). "Blood donation guidelines recommended by the World Health Organization (WHO) and many blood collection agencies are largely based on research that assessed only what study participants said they would do – not their observed behaviour when donating blood," says Nicola Lacetera, Assistant Professor in UTM's Department of Management. "These are two very different things." Using ...

Frontiers news briefs: May 23

2013-05-24
Frontiers in Plant Science Automated conserved noncoding sequence (CNS) discovery reveals differences in gene content and promoter evolution among grasses Within the genome of each species, there are thousands of stretches of DNA that undergo little change in position and sequence over millions of years, but do not code for any proteins. Some of these evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are known to regulate the expression of other genes or the condensation of chromosomes, but the function of many CNSs remains unknown. Michael ...

LAST 30 PRESS RELEASES:

AI can spot which patients need treatment to prevent vision loss in young adults

Half of people stop taking popular weight-loss drug within a year, national study finds

Links between diabetes and depression are similar across Europe, study of over-50s in 18 countries finds

Smoking increases the risk of type 2 diabetes, regardless of its characteristics

Scientists trace origins of now extinct plant population from volcanically active Nishinoshima

AI algorithm based on routine mammogram + age can predict women’s major cardiovascular disease risk

New hurdle seen to prostate screening: primary-care docs

MSU researchers explore how virtual sports aid mental health

Working together, cells extend their senses

Cheese fungi help unlock secrets of evolution

Researchers find brain region that fuels compulsive drinking

Mental health effects of exposure to firearm violence persist long after direct exposure

Research identifies immune response that controls Oropouche infection and prevents neurological damage

University of Cincinnati, Kent State University awarded $3M by NSF to share research resources

Ancient DNA reveals deeply complex Mastodon family and repeated migrations driven by climate change

Measuring the quantum W state

Researchers find a way to use antibodies to direct T cells to kill Cytomegalovirus-infected cells

Engineers create mini microscope for real-time brain imaging

Funding for training and research in biological complexity

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: September 12, 2025

ISSCR statement on the scientific and therapeutic value of human fetal tissue research

Novel PET tracer detects synaptic changes in spinal cord and brain after spinal cord injury

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Benchmark study tracks trends in dog behavior

OpenAI, DeepSeek, and Google vary widely in identifying hate speech

Research spotlight: Study identifies a surprising new treatment target for chronic limb threatening ischemia

Childhood loneliness and cognitive decline and dementia risk in middle-aged and older adults

Parental diseases of despair and suicidal events in their children

Acupuncture for chronic low back pain in older adults

Acupuncture treatment improves disabling effects of chronic low back pain in older adults

[Press-News.org] Multiple research teams unable to confirm high-profile Alzheimer's study